Benjamin F. Edwards & Company, Inc. Glaukos Corp Transaction History
Benjamin F. Edwards & Company, Inc.
- $5.69 Billion
- Q2 2024
A detailed history of Benjamin F. Edwards & Company, Inc. transactions in Glaukos Corp stock. As of the latest transaction made, Benjamin F. Edwards & Company, Inc. holds 198 shares of GKOS stock, worth $31,723. This represents 0.0% of its overall portfolio holdings.
Number of Shares
198
Previous 49
304.08%
Holding current value
$31,723
Previous $5,000
360.0%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding GKOS
# of Institutions
345Shares Held
46.7MCall Options Held
132KPut Options Held
188K-
Black Rock Inc. New York, NY8.04MShares$1.29 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.87MShares$941 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA2.18MShares$350 Million0.05% of portfolio
-
State Street Corp Boston, MA1.95MShares$313 Million0.01% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN1.64MShares$263 Million0.06% of portfolio
About GLAUKOS Corp
- Ticker GKOS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 47,596,900
- Market Cap $7.63B
- Description
- Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...